Results 131 to 140 of about 33,753 (206)

Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome. [PDF]

Front Endocrinol (Lausanne), 2022
Liu C, Zhao Q, Zhao Z, Ma X, Xia Y, Sun Y, Zhang D, Liu X, Zhou Y.   +8 more
europepmc   +1 more source

Short-term outcomes of non-ST segment elevation acute coronary syndrome after percutaneous coronary intervention: a single-center speckle tracking echocardiographic study in Vietnam. [PDF]

Front Cardiovasc Med
Trinh HV, Nguyen DV, Do LD, Le BT, Nguyen HTT.   +4 more
europepmc   +1 more source

Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis. [PDF]

BMJ Open, 2022
Demandt JPA, Zelis JM, Koks A, Smits GHJM, van der Harst P, Tonino PAL, Dekker LRC, van Het Veer M, Vlaar PJ.   +8 more
europepmc   +1 more source

Prognostic Role of Pan-Immune-Inflammatory Value in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. [PDF]

J Cardiovasc Dev Dis
Byoun JT, Yun KH, Jo S, Joo D, Cho JY.
europepmc   +1 more source

Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial. [PDF]

Front Cardiovasc Med, 2022
Wu X, Guo M, Shi S, Shi S, Deng Y, Wang S, Wang Y, Wang P, Chen K.   +8 more
europepmc   +1 more source

Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention. [PDF]

Diabetol Metab Syndr, 2022
Liu C, Liu X, Ma X, Cheng Y, Sun Y, Zhang D, Zhao Q, Zhou Y.   +7 more
europepmc   +1 more source

Aspirin Desensitization in the Course of Non-ST-Segment Elevation Acute Coronary Syndrome: A Case Report and Review of the Literature. [PDF]

Cureus
Faliouni H, Alaoui LG, Fihri Y, Laaroussi M, Lamtai M, Lakhal Z, Benyass A.   +6 more
europepmc   +1 more source

Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. [PDF]

Cardiovasc Diabetol, 2022
Liu C, Zhao Q, Ma X, Cheng Y, Sun Y, Zhang D, Liu X, Zhou Y.   +7 more
europepmc   +1 more source

Improving the non-ST-segment elevation acute coronary syndrome (NSTEACS) pathway using quality improvement methodology. [PDF]

BMJ Open Qual
Goodfellow S, Goodfellow J.
europepmc   +1 more source

Temporal trends in diagnosis, treatment, and outcome for non-ST-segment elevation acute coronary syndrome in three regions of China, 2008-2015. [PDF]

Chin Med J (Engl), 2021
Liu R, Sun YQ, Hou XX, Zheng Y, Huffman MD, Anderson CS, He L, Xia SJ, Jiang C, Du X, Dong JZ, Ma CS.   +11 more
europepmc   +1 more source